Skip to content

Efficacy Of Pre-caesarean Povidone-iodine Vaginal Cleansing in Preventing Surgical Site Infection at ATBUTH Bauchi: A Randomized Controlled Trial

Efficacy Of Pre-caesarean Povidone-iodine Vaginal Cleansing in Preventing Surgical Site Infection at ATBUTH Bauchi: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202405865325160
Enrollment
108
Registered
2024-05-14
Start date
2024-05-02
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-caesarean section surgical site infection Pregnancy and Childbirth

Interventions

Sponsors

self
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. All consenting pregnant women admitted to ATBUTH Bauchi for either an elective or emergency caesarean section 2. Gestational age: =28 weeks.

Exclusion criteria

Exclusion criteria: 1. Subjects known to be hypersensitive to povidone-iodine 2. Presence of features of subclinical/clinical chorioamnionitis 3. HIV in Pregnancy 4. Diabetes mellitus in pregnancy 5. Patient on long time steroid intake 6. Unconscious patient 7. Patients with cord prolapse, face presentation with ruptured membranes or placenta previa

Design outcomes

Primary

MeasureTime frame
Surgical Site Infection: wound infection will be diagnosed when the surgical wound has either oedema, erythema, discharge, exudate, hematoma, novel undue tenderness at incisional site or wound gaping with or without or fever (temperature of =380C) requiring antibiotics. These will be assessed on day three after surgery when the wound will be opened for inspection. Endometritis will be diagnosed by presence of any two of the following; fever (temperature of =380C) after 24 hours, lower abdominal pain, novel undue uterine tenderness, uterine subinvolution or offensive vaginal discharge.

Secondary

MeasureTime frame
Onset of SSI, febrile morbidity (temperature of =380C), reaction to povidone-iodine (itching, erythema, blister at the application area), burst abdomen, septic shock, and death attributed to infection among study groups

Countries

Nigeria

Contacts

Public ContactIsmail Tiamiyu

Unit consultant

Tiamiyuismail21@yahoo.com+2348066967221

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026